Business Development Agent
AI-Powered Deal Intelligence for Asset Commercialization and Strategic Partnering
An AI-driven platform for deal intelligence, strategic positioning, and exit enablement in pharmaceutical asset transactions. Designed to bridge the gap between scientific discovery and market realization, it autonomously generates investor-ready materials, deal structures, and partnership frameworks aligned to each asset’s modality, stage, and market trajectory.